Hypertriglyceridemia and its impact on mitotane monitoring in adrenocortical carcinoma
Mitotane is used for treatment of advanced adrenocortical carcinoma. It is administered when the carcinoma is unresectable, metastasized, or at high-risk of recurrence after resection. In addition, mitotane is considered to have direct adrenolytic effects. Because of its narrow therapeutic-toxic range, therapeutic drug monitoring (TDM) is warranted. In 2020, a left-sided adrenal gland tumor was found (5.8 cm) in a 38-year-old man. Considering the size of this lesion and inability to exclude an adrenocortical carcinoma on imaging, a laparoscopic adrenalectomy was performed. Histopathologic exam... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journalarticle |
Erscheinungsdatum: | 2023 |
Schlagwörter: | Medicine and Health Sciences / Adult / Male / White / Belgium / Adrenal / Endocrine-related cancer / Unusual effects of medical treatment / December / 2023 / SERUM-LIPOPROTEINS |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28539124 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://biblio.ugent.be/publication/01J0V080VDZX4TZFEDR8TXJV0E |